Market Overview

UPDATE: Piper Jaffray Raises PT to $9 on Christopher & Banks on Q1 Comps Outlook

Related CBK
MId-Day Losers From December 4: Kindred Biosciences, Barnes & Noble, Aeropostale
Stocks Hitting 52-Week Lows

Piper Jaffray maintained Christopher & Banks (NYSE: CBK) with an Overweight rating and raised the price target from $6.00 to $9.00.

Piper Jaffray analyst Neely J.N. Tamminga noted, "We are reiterating our Overweight rating on CBK shares on the heels of the company's FQ4 release and early indications that FQ1 same-store sales are estimated to be up at least +low 20s%. The path to profitability is clear to us as we are now, for the first time in three years, projecting earnings (not losses) per share for CBK. We note that management is already showing signs of prudent, thoughtful growth initiatives in opening outlet stores, focusing on e-commerce, and investing more payroll into stores."

Christopher & Banks closed at $6.57 on Wednesday.

Latest Ratings for CBK

DateFirmActionFromTo
Dec 2014Piper JaffrayDowngradesOverweightNeutral
Nov 2014Brean CapitalInitiates Coverage onBuy
Nov 2014Brean CapitalInitiates Coverage onBuy

View More Analyst Ratings for CBK
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Price Target Analyst Ratings

 

Related Articles (CBK)

Around the Web, We're Loving...

Get Benzinga's Newsletters